Recent studies have highlighted the importance of several key genes and molecular pathways, including Dedicator of Cytokinesis 3 (DOCK3), in tumor progression and therapeutic response, drawing attention to the potential role of DOCK3 in various cancers (5, 6). The gene discussed is DOCK3; the disease is neoplasm.